In conclusion, HPGD, PACS1, and TDP2 in CRC plasma samples were demonstrated as potential prognosis biomarkers of CRC, we hope that our results will enable future studies in incorporating cfRNA in the detection, monitoring, and diagnosis of premalignant CRC. The gene discussed is HPGD; the disease is colorectal carcinoma.